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ABSTRAK 
PENGENALAN 
‘Nonarteritic Anterior Ischaemic Optic Neuropathy’ (NAION) adalah penyakit di kalangan 
orang yang berusia 50 tahun dan ke atas yang menyebabkan kebutaan kekal. Penilaian dan 
pemantauan penyakit ini perlu untuk menilai kerosakan dari segi struktur dan fungsi saraf 
mata.  Ujian Electrophysiology penglihatan (pattern electroretinogram (PERG) dan pattern 
visual evoked potential (PVEP)) berkebolehan mengesan degeneratif saraf ‘axon’ dan ‘retina 
ganglion cells (RGC)’ di dalam pesakit ini. Penilaian struktur lapisan fiber saraf retina 
(RNFL) dengan menggunakan ujian ‘Optical Coherence Tomography’ (OCT) menghasilkan 
imej RNFL secara 3 dimensi, membuat penilaian ketebalan RNFL secara objektif dan dapat 
mengesan kerosakan struktur. Ia merupakan ujian pelengkap kepada ujian struktur dan fungsi 
saraf mata. 
OBJEKTIF  
Pengkajian keatas maklumbalas ujian electrophysiology penglihatan dan lapisan fiber saraf 
retina (RNFL) dalam pesakit NAION. Korilasi di antara ujian elektrofisiologi penglihatan 
dengan ketebalan RNFL turut dikaji.  
METODOLOGI DAN BAHAN 
Satu kajian perbandingan hirisan lintang telah dijalankan di Hospital Universiti Sains 
Malaysia melibatkan 42 orang subjek daripada pesakit NAION dan normal. Pemeriksaan 
lengkap dijalankan bagi pengesahan penyakit NAION. Ujian struktur RNFL dilakukan 
menggunakan Cirrus SD-OCT (Carl Zeiss Meditec Inc, USA) dengan kekuatan penunjuk 
yang bagus (≥ 6/10), manakala PERG (size ‘checks’0.8º) dan PVEP (size ‘checks’0.25º) 
dilakukan oleh juru teknik yang terlatih. Analisa statistik dilakukan dengan menggunakan 
ujian ‘Mann-Whitney’ dan ‘Spearman’s correlation coefficient’. 
 xiii 
 
KEPUTUSAN 
Terdapat signifikasi statistik pengurangan ‘amplitude’ dan pemanjangan tempoh ‘latency’ 
PVEP dalam pesakit NAION (p<0.001). Terdapat juga signifikasi statistik pengurangan pada 
‘amplitude’ (p<0.001) dan pemanjangan tempoh ‘latency’ (p<0.001) PERG. Terdapat 
signifikasi statistik pengurangan ketebalan RNFL secara keseluruhan dalam pesakit NAION 
(p<0.001). Ketebalan RNFL menunjukkan tiada signifikasi statistik dengan ‘latency’ dan 
‘amplitude’ PVEP dan PERG.  
KESIMPULAN 
Electrophysiology penglihatan dan analisis RNFL menunjukkan perubahan yang signifikasi 
tehadap para pesakit NAION. Hal ini menyokong yang PERG, PEVP dan OCT merupakan 
ujian komplimentari untuk penilaian dan pemantauan perubahan pada fungsi dan struktur 
saraf mata dalam pesakit NAION.  
KATA KUNCI 
‘Nonarteritic anterior ischaemic optic neuropathy (NAION)’, pattern electroretinogram 
(PERG), pattern visual evoked potential (PVEP), lapisan fiber saraf retina (RNFL). 
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ABSTRACT 
INTRODUCTION 
Nonarteritic anterior ischaemic optic neuropathy (NAION) is a disease among elderly more 
than 50 years old that leading to blindness. Assessment and monitoring of this disease is 
essential in order to evaluate the structural and functional damage. Visual electrophysiology 
tests (pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP)) able to 
detect axonal degeneration and functional impairment of retina ganglion cells (RGC) in 
patient with NAION. Assessment of Retinal Nerve Fiber Layer (RNFL) with Optical 
Coherence Tomography (OCT) provides 3-Dimensional image of RNFL, objectively evaluate 
the RNFL thickness and detection of structural damage. It compliments the existing standard 
structural and functional test.  
OBJECTIVE  
To evaluate visual electrophysiology response and retina nerve fibers layer (RNFL) thickness 
in NAION. The correlation between visual electrophysiology with RNFL thickness were also 
evaluated. 
MATERIALS AND METHODS 
A comparative cross sectional study was conducted in Hospital Universiti Sains Malaysia 
involving 42 samples of NAION patients and controls. A complete ocular examination was 
done to confirm the diagnosis of NAION. Evaluation of structural changes of RNFL was 
conducted using Cirrus SD-OCT (Carl Zeiss Meditec Inc, USA) with good signal strength (≥ 
6/10). PERG (0.8º checks size) and PVEP (0.25º checks size) was conducted by a trained 
technician. Mann-Whitney test and Spearman’s correlation coefficient analysis were used in 
statistical analysis. 
 xv 
 
RESULTS 
There were statistically significant reduction in amplitudes and prolonged in latencies of 
PVEP in NAION patients (p<0.001). There were also significant reduction in magnitude of 
amplitude (p<0.001) and prolonged latency in PERG (p<0.001). There was also significant 
thinning of Mean RNFL thickness in NAION patients (p<0.001). No significant correlation 
between RNFL and latency and amplitudes of PVEP and PERG. 
CONCLUSION 
Visual electrophysiology tests and RNFL analysis has shown significant changes in NAION 
patients. This supports that PERG, PVEP and OCT are complimentary tests in assessment 
and monitoring structural and functional damage in NAION.  
 
KEY WORDS 
‘Nonarteritic anterior ischaemic optic neuropathy (NAION)’, pattern electroretinogram 
(PERG), pattern visual evoked potential (PVEP), retina nerve fiber layer (RNFL). 
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Introduction.  
 
1.1 Nonarteritic anterior ischaemic optic neuropathy (NAION). 
 
Nonarteritic anterior ischaemic optic neuropathy (NAION) is the most common type of 
ischaemic optic neuropathy. This condition ultimately lead to permanent visual loss in 
middle-aged and elderly population. It can be defined as acute optic nerve ischaemia due to 
microcirculatory embarrassment. This lead to disturbance of perfusion to the proximal 
portion of the optic nerve supplied by the posterior ciliary artery. Nonarteritic implies to the 
condition whereby the ischaemia does not attributed from vasculitis in which commonly due 
to giant cell arteritis. Hayreh (1974) defined “anterior” to denote optic nerve head swelling in 
acute phase compared to rarer posterior type with normal disc appearance. Although the 
condition classically occurred in patients age 50 years and older, the age group shifted 
towards younger age group in patient with Diabetes Mellitus and Hypertension. (Repka MX 
et al., 1983). 
 
Limited data reported on the incidence of NAION in other countries apart from United States. 
One study reported about the incidence of NAION in Asian country in Beijing done by Xu L 
et.al (2007), the annual incidence in Chinese population approximately 6.25 per 100,000. The 
incidence is higher in United States and this is comparable to commoner disease among 
Caucasians (Lee MS et al., 2011; Johnson LN and Arnold AC, 1994). 
 
Classically, patients presented with acute onset of painless unilateral loss of vision or field 
defect. The vision loss commonly take place upon awakening and describe as diffuse blurring 
or cloudiness of vision. If they have field defect, typically it involved inferiorly which 
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classically describe as altitudinal field defect. (Hayreh SS and Zimmerman B, 2005). Visual 
acuity can be vary, ranging from 20/15 to as worse as no light perception. Surprisingly, in a 
study done by Hayreh SS and Zimmerman MB (2008), a normal or near normal visual acuity 
during presentation found in 50% of patients. Thus, NAION cannot be overlook in patient 
with good visual acuity. Patients also have colour vision defect in keeping with the degree of 
visual acuity loss. 
 
In unilateral case, a relative afferent pupillary defect is always present. Small number of 
patient will experience eye pain or discomfort and pain on eye movement that typically a 
feature of optic neuritis is absent in NAION, thus can discriminate between these two disease 
conditions. (Swartz Ng et al., 1995). 
 
Fundus examination in NAION reveals optic disc swelling either diffuse or segmental with 
peripapillary flame shape hemorrhage. The unaffected contraleral eye usually will have small 
or absent physiology cup, describe as “disc at risk” (Miller NR, 2011 and Atkins EJ et al., 
2010). Hayreh SS and Zimmerman MB came out with a new disease entity describe as 
“incipient NAION” and has been occurred in higher number of cases in diabetic patients. In 
these cases, patients experienced disc edema but asymptomatic. Then it resolves and recur 
symptomatically in 25% of patient. 
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1.2 Pathogenesis of NAION. 
Pathogenesis of NAION is still unknown. It postulated as a result of microcirculatory 
insufficiency at the level of the optic nerve head blood supply. Many studies regarding the 
aetiology of NAION focused on Short Posterior Ciliary Arteries (SPCA) and choroidal 
circulation and factors that affecting this vessel. Knox DL et al (2000) from histopathology 
evidence documented infarction of the optic nerve head. Oliver JM et al (1990) and Onda E 
et al (1995) in their autopsy eye demonstrated that the optic disc is supplied by partial or 
complete vascular circle derived from the SPCAs. This vascular circle may have distinct 
upper and lower halves division which consistent with altitudinal damage if it is affected. 
Fluorescein angiography further defined this location of vessels that compromise in NAION. 
Hayreh SS (1990) found delayed in filling of prelaminar optic disc from Fluorescein 
Angiography while Arnorld AC and Hepler RS (1994) suggest that the level of vascular 
occlusion lies within the paraoptic branches of the SPCAs. Recent study using current 
technology further supported this evidence. Leiba H et al (2000) found decreased in optic 
nerve head blood flow measured by Laser Doppler flow study. 
 
Several risk factors were identified that attributed to reduction on optic nerve head perfusion 
in NAION. Several studies have shown that systemic disease like Hypertension and Diabetes 
Mellitus have been associated with NAION. (Boghen DR and Glaser JS., 1975; Repka MX et 
al., 1983; Hayreh SS et al., 1994; Ischaemic Optic Neuropathy Decompression Trial Study 
Group, 1996). Jacobson DM et al (1997) found smoking and hypercholesterolemia as another 
risk factors.  
 
 4 
 
Structure of the optic disc play a role in NAION. The discs in patients with NAION are often 
small in diameter and small or absent in cups suggesting ‘crowding’ disc may impart in 
pathogenesis of this disease. This crowding postulated that it will cause mechanical 
obstruction to axoplasmic flow, thus produces intracellular axonal swelling and compromise 
microcirculation in that crowded region. Another possibilities is secondary obstruction to 
axoplasmic flow occurs after acute ischaemia will result in ganglion cell death. (Feit RH et 
al., 1984; Doro S and Lessell S, 1985; Beck RW et al., 1987) 
 
Apart from mechanical factors, Hayreh SS et al (1994) has postulated that nocturnal 
hypotension may impart in pathogenesis of NAION. He stated that hypotension that normally 
occurs during sleeping may compromise optic disc circulation, in particular in patients with 
systemic hypertension where exaggeration of nocturnal drop in blood pressure occurs. It 
further aggravated by aggressive treatment with antihypertensive medication that 
administered at night. Landau K et al (1996) in contrast found that slower rise in mean blood 
pressure in early morning in patients with NAION. 
 
Hayreh SS et al (1999) in his study found that impairment in the normal autoregulatory 
mechanism that control the blood flow in the optic nerve vasculature play a role in the 
pathogenesis. In his study, he found that impairment of this autoregulation as a result of 
endogenous serotonin released within atherosclerotic plaque and also mediated by 
endhothelin that both results in arterioles vasoconstriction. 
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1.3 Treatment and Management of NAION. 
Management of NAION is still questionable and several therapies have been used but none of 
the treatment applied has been shown to be effective. Management dilemma surrounding this 
disease are no establish treatment in acute NAION and no preventive treatment for a 
subsequent attack on the fellow eye which estimated to be 15%-25%. (Kuppersmith MJ et al., 
1997). Wide range of treatment in NAION presumed to act on thrombosis, on the blood 
vessels, on reduction of disk edema in acute stage which will ameliorate damage and 
preserved vision, and few treatment presumed to have a neuroprotective effect. 
 
Ischaemic Optic Neuropathy Decompression Trial (IONDT) compared the visual outcomes 
of patients observed without treatment with those of patients treated with optic nerve 
fenestration. Patient undergone optic nerve fenestration showed improvement of three lines of 
visual acuity in earlier study (IONDT. 1996). However recent IONDT (2000) clinical trials 
evaluated this surgical modality have shown that no differences in visual outcome compared 
to untreated group and patient undergone optic nerve fenestration have experienced more 
deterioration in visual acuity.  
 
Corticosteroid has been used as primary medications, either systemic steroid or intravitreal 
injection of triamcinolone to reduce the disc edema in acute stage. Improvement of visual 
acuity has seen in steroid-treated group as compared to untreated in several studies. (Hayreh 
 6 
 
SS and Zimmerman MB, 2008; Hayreh and Zimmerman, 2007; Hayerh 2008; Hayreh 1974). 
However, this studies done in a very small group of patient and larger sample size 
encouraged in future study. 
 
Several therapies have been proposed including anticoagulation, aspirin, sub Tenon injections 
of vasodilators, intraocular pressure lowering agents such as brimonidine, thrombolytic 
agents and hyperbaric oxygen. (Ellenberger C Jr et al., 1974; Kollarits CR et al., 1981; 
Batelho PJ et al., 1996; Arnold Ac et al., 1996; Fazzone HE et al., 2003). Unfortunately none 
of this therapy has been proved to be effective. 
 
Although no validate treatment in NAION, optimisation of medical conditions such as 
Diabetes Mellitus, Hypertension and Hypercholesterolemia is important in prevention of the 
attack on the fellow eye. (Newman NJ et al., 2002). Although smoking has a weak correlation 
with NAION, it is advisable to stop smoking to prevent cardiovascular disease. (Hayreh SS et 
al., 2007). Furthermore, patients in whom NAION developed are at risk for developing 
cerebrovascular and cardiovascular events such as transient ischaemic attack, stroke and 
myocardial infarction. 
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1.4 Pattern Visual Evoked Potential (PVEP) in NAION. 
Visual Evoked Potential (VEP) is a cortical response generated by an electrical potential 
gradient recorded clinically by placing wire electrodes adjacent to the occipital cortex and to 
a non-visual area of the brain. It reflects the patency of visual pathway and to assess optic 
nerve function and its projection to the visual cortex. In PVEP, the stimulus used to generate 
the wave is an alternating high contrast checkerboard. The responses stimulate by this stimuli 
have less intra- and inter-individual variability and much sensitivity and accuracy in detecting  
minor visual pathway abnormality compare to Flash VEP and the most preferred test in 
clinical disease. (American Clinical Neurophysiology Society. Guideline 9B: Guidelines on 
visual evoked potentials. 2006). 
 
ISCEV latest guidelines on standard method of performing and recording PVEP provide 
comprehensive instructions in eliminating errors. Non-pathophysiologic parameters that 
affect the PVEP reading such as pattern size, pattern contrast, mean luminance, signal 
filtering, patient age, refractive error, poor fixation, and miosis were considered during 
performing PVEP (Odom JV et al., 2010). Prolongation of P100 latency measured in PVEP 
considered the most reliable parameter in detecting clinical abnormality. It less affected by 
degree of patient cooperation and technical factors. (American Clinical Neurophysiology 
Society. Guideline 9B: Guidelines on visual evoked potentials. 2006). 
 
Several studies reported on abnormality in PVEP recording in NAION patients. (Wilson WB 
1978; Janaky M et al., 2006; Atilia H et al., 2006, Parisi V et al., 2008). Variations in PVEP 
findings reported in their study. The initial study by Wilson WB (1978) found that severe 
reduction in amplitude with little or no change in latency. In contrast to more recent study by 
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Janaky M et al (2006) found prolongation in latency as well as reduction in amplitude. 
Interestingly, in this study they found abnormal changes in VEP in terms of waves and 
latency of the fellow unaffected eye suggested early detection of involvement of the fellow 
eye. However further longitudinal study and bigger sample size needed to evaluate this 
findings. 
 
Few animal studies conducted this electrophysiological evaluation for further understanding 
of pathogenesis of this disease. (Chen CS., 2008; Chuman H, 2014; Bernstein SL., 2011). 
Berstein SL (2011) and Chen CS (2008) found similar findings of reduction in amplitude but 
normal in latency in their animal models of NAION. The VEP amplitude depression 
persistent in animal study showed that permanent degradation of optic nerve electrical 
activity. Chuman H (2014) further evaluate the use of PVEP in the treatment of NAION. As 
the results of animals study comparable to the human eye with NAION, this provide further 
understanding of the human axonal damage after axonal ischaemia.  
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1.5 Pattern Electroretinogram (PERG) and NAION. 
In NAION, circulatory insufficiency within the optic nerve head presumed to be a cause 
although specific mechanism remains elusive. Although PERG is a good tool of assessment, 
the role of PERG is still minimal in assisting management of NAION. With PERG, it helps in 
objectively evaluate functional deficit of patient and further understanding of pathogenesis of 
the disease. The measurements will convey regarding the actual site of involvement, whether 
it confined to the optic nerve or other layers of retina would also involve. Besides estimation 
of visual acuity and visual field, it contribution will demonstrate the extent of visual 
deterioration of patient, thus will aid in prognosis.  
 
To better understanding regarding the role of PERG in NAION, review of histopathologic 
evidence are reported by animal and human study. In primate-induced NAION model by 
Chen CS et al (2008), histopathologic evidence showed reduction of number of cells in the 
ganglion cell layer, axonal disruption and thinning of RNFL. This will give rise to reduction 
of PERG N95 amplitude selectively as N95 is generated in relation to retina ganglion cell 
function. This study supported by another animal study done by Chuman et al (2012), in 
rodent-induced NAION showed similar findings of loss of RGC however 
electrophysiological study in this rodent did not found any significant changes in PERG. 
Comparable to human study by Levin LA and Louhab A (1996), reported a case of evidence 
of human RGC apoptosis in NAION. The rate of RGC death in human is questionable, but it 
takes 2 to 12 weeks based on monkey study (Quigley HA et al., 1995). Atilia H et al (2006) 
found a difference in her study whereby retrograde degeneration occurred on the RGC axons 
as a result of compromise to the optic nerve or direct damage to the RGC bodies. 
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Electrophysiological studies done in NAION patients still limited. Only few papers reporting 
on PERG recordings in NAION patients. Parisi et al (2008) found reduction in amplitudes as 
well as delayed implicit times. Comparable to this study, Janaky M et al (2006) and Atilia H 
et al (2006) found decreased in N95 amplitude but no difference in latency. Froehlich J and 
Kaufman DI (1994) done a study in acute stage of NAION showed similar findings of 
reduction in N95 amplitude. Janaky M et al (2006), Atilia H et al (2006) and Froehlich J and 
Kaufman DI (1994) found similar findings in their study that P50 amplitude and latency was 
normal. This would explain that P50 usually affected by dysfunction of the macula which the 
wave arise largely from macular photoreceptors. In contrast, Parisi et al (2008) found delayed 
in P50 latency. This variable response was found to be influenced by the difference in disease 
severity and in PERG recording strategy used. 
 
The knowledge on the PERG in NAION had been further expanded in a study done by 
Froehlich J and Kaufman DI (1994) who studied the response of PERG in patients with 
NAION and Optic Neuritis. In that study, they reported a reduction in N95 amplitude with no 
change in patients with optic neuritis in early course of the disease. This findings had 
concluded that PERG had a potential diagnostic ability to diagnose NAION if the judgement 
of making diagnosis is equivocal especially in younger patient without medical 
comorbidities. More studies require to further evaluate and support this findings for future 
use.  
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However, PERG is still not routinely used in daily clinical practice. It requires demanding 
and standardised recording technique plus experienced and trained operators to achieve 
reliable and reproducible results. (Bach M et al., 2007). Efforts are being undertaken to 
address these issues. The International Society for Clinical Electrophysiology of Vision 
(ISCEV) had, in 2012, published a guideline on PERG. Other electrophysiological test such 
as multifocal ERG and multifocal PERG are now emerged and being extensively studied. 
Reporting PERG based on index amplitude and latency of small to large checks are now 
widely considered. (Bach M et al., 2013). 
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1.6 Optical Coherence Tomography (OCT) in NAION. 
 
Optical coherence tomography (OCT) has become an important tools for objective 
assessment and measurements of the optic nerve head and peripapillary retinal nerve fiber 
layer thickness (RNFLT). With emergence of this new technology, it becomes a 
complimentary tool to a clinical examination and fundus photography. The commonly used 
Cirrus HD-OCT, a spectral domain OCT device has offered a faster scan speed and a higher 
image resolution, providing high quality image for RNFL imaging. Thus, with this 
advantages, it provides superiority in terms of reproducibility and reliable measurement, its 
diagnostic capability and the strength between structure-function relationships. Besides 3-
dimensional imaging of the RNFL, it has low measurement variability (Leung CK et al., 
2009). 
 
OCT allows direct measurement of RNFL thickness by in vivo visualisation of the retinal 
layers and anatomical changes. In patients with NAION, during the acute phase of ischaemic 
insult, there is acutely swelling of RNFL and thinning after 3 to 6 months which correlate 
with visual field loss. During this acute phase, the swelling of the RNFL will mask the effect 
of measuring axonal loss. Thus, analysis of ganglion cell layer at this stage showed 
significant thinning as compared to RNFL. This would indicate that measurements of RGC 
layer in OCT represents a biomarker of early structural loss in NAION. Maekubo T et al 
(2013), in their experimental study found that OCT images are analogous to histologic cross-
sectional findings. This ganglion cell layer undergone axonal damage directly or as a result of 
retrograde degeneration following ischaemic insult. Similar to this study, Ho JK et al (2013) 
found that measurements of retinal layer changes using OCT is an equal to histologic findings 
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of retina ganglion cell axon loss. This concluded that this non-invasive method is equal to 
dissection of difference structure of retinal layers. 
Apart from measurement of RNFL thickness in NAION, it allows objective analysis of optic 
nerve head parameters. This parameters are equally important to RNFL analysis since it is 
known in NAION patients that the disc area is small and small cup-to-disc ratio. This 
condition usually referred to as the “disc at risk”. Saito H et al (2006) and Danesh Meyer HV 
et al (2005) have confirmed this findings in patient with NAION. Comparable to this study 
done by Contreras et al (2007), patients with NAION have lower cup to disc ratio as 
compared to the normal population. 
 
Variability in clinical presentations in term of visual field defects and optic disc pallor in 
NAION makes these two major diagnostic criteria need further evaluation. In contrast to 
objective evaluation of visual field defect with standard automated perimetry, assessment of 
optic disc pallor is highly dependent on clinicians. The extent and degree of pallor 
measurements can be influenced by many factors including media interference for example 
cataract or pseudophakic eye. Janaky M et al (2006) found that degree of optic disc pallor did 
not correlate well with visual acuity. This assessment could be subjective with high inter-
individual variations. Thus, with OCT it helps in objectively measured the damage that has 
occurred to the retina nerve fiber layer after the ischaemia that aid in more accurate visual 
prognosis. 
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Apart from quantification of RNFL and optic nerve head measurements in further 
understanding pathogenesis of this disease, it also helps in identification of different pattern 
of RNFL involvement pertaining to visual field loss in NAION. Deleon-Ortega J et al (2006) 
showed that visual field mean deviation correlated better with OCT RNFL thickness. Thus, it 
correlate better structural and functional assessment. Additionally, it produced the 
information regarding the relationship between RNFL thickness and Visual Field (VF) 
sensitivity in a non-affected field. Chan CK et al (2009) showed that eyes affected by NAION 
had thinner RNFL than control eyes in regions that unaffected hemifield. This interesting 
ﬁnding suggests that measurement of RNFL with OCT would tell the extension of RNFL 
involved beyond the field measured with standard automated perimetry. This information has 
prospective in term of estimation of visual potential and for follow-up of patients.   
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1.7 Rationale of this study. 
 
Clinical assessment of NAION using slit lamp biomicroscopy and fundus photography yield 
high inter-individual variability. Assessment of pallor of optic disc affected by media of the 
eye (e.g cataract or pseudophakic) and gives false impression about the real colour of the 
disc. In some measure, the degree of pallor does not really correlate well with visual acuity. 
 
Hitopathologic study of an eye with NAION has shown loss of cells and their axons, thinning 
of RNFL and reduced number of Retinal Ganglion Cells (RGCs). Structural assessment of 
NAION with latest technology using OCT has gained popularity compliments conventional 
method of assessment of this disease. It produces 3-dimensional image of RNFL with low 
measurement variability. It is a non-invasive technique, provides objective evaluation of 
RNFL thickness and detection of structural loss in patient with NAION. 
 
Functional assessment using electrophysiological tests such as PVEP and PERG aids in 
further characterisation of pathophysiology of the diseasethat still in questions. Measurement 
of P100 amplitude and latency in PVEP represents most of cortical response. In PERG, 
measurement of P50 and N95 amplitude and latency provides assessment of macula fibers 
and Retinal Ganglion Cells function respectively. This measurements will objectively 
evaluate the functional damage in NAION, compliments the structural evaluation. 
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The relationship between structural and functional alterations has never been thoroughly 
evaluated in NAION. This study focuses on the visual electrophysiological changes in 
NAION patients and to establish correlation between it with the overall RNFL thickness from 
the OCT. Perhaps this test can be a complimentary tests to conventional way of assessing and 
monitoring patient with NAION. 
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2.0  OBJECTIVE.  
2.1 General Objective  
To evaluate the relationship of RNFL thickness to electrophysiological changes in 
patient with NAION. 
 
2.2  Specific Objectives 
1.  To compare PVEP changes in NAION patients with control group.  
2.  To compare PERG changes in NAION patients with control group. 
3.  To compare RNFL thickness in NAION patients with control group. 
4.  To determine the correlation between mean RNFL thickness and PVEP amplitude and 
latency in NAION patients. 
5.  To determine the correlation between mean RNFL thickness and PERG amplitude 
and latency in NAION patients. 
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2.3  Research questions. 
1.  Is there any difference between PVEP amplitude and latency measurements in 
NAION patients compared to control group? 
2.  Is there any difference between PERG amplitude and latency measurements in 
NAION patients compared to control group? 
3.  Is there any difference between RNFL analysis in NAION patients compared to 
control group? 
4.  Is there a correlation between mean RNFL thickness and PVEP amplitude and latency 
in patient with NAION? 
5.  Is there a correlation between mean RNFL thickness and PERG amplitude and latency 
in patient with NAION? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19 
 
 
 
 
 
 
 
 
                                                                             Chapter 3
      
                                                                      
 
 
    
   MATERIALS &METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19 
 
3.0  Methodology. 
3.1  Research design: 
A case control study was the research design for this study. 
 
3.2  Population, Place and period of study: 
 
3.2.1 Study population:    
NAION patients who attended Neuroopthalmolgy clinic at Hospital Universiti Sains 
Malaysia (HUSM), Kubang Kerian.  
3.2.2 Place of study: 
 Ophthalmolgy Clinic, HUSM. 
3.2.3 Duration of Study: 
 This study was carried out from June 2013 until November 2014.  
 
3.3 Sampling method: 
 
3.3.1 Selection Criteria: 
Convenient sampling was applied on NAION patients under HUSM eye clinic follow 
up who fulfilled the criteria of this study. 
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3.3.2      NAION Group Inclusion Criteria  
• Age more than 40 years old. 
• Patient diagnosed with NAION based on history of unilateral acute vision loss, 
Positive Relative Afferent Pupillary Defect (RAPD), optic disc swelling and visual 
field defect. 
• Confirmed case of NAION for minimum of 6 months. 
• Patient who understand the nature of study and willing to sign the informed consent 
form. 
3.3.3 NAION Group Exclusion criteria. 
• Patient presented with other cause of optic neuropathy. 
• Patient with optic disc abnormality. 
• Presence retina pathology for example retinal detachment, maculopathy, panretina 
photocoagulation scar. 
• Presence of media opacity including dense cataract, cornea opacity, vitreous 
haemorrhage that affected quality of OCT image.  
• Patient diagnosed with glaucoma. 
• Presence of intraocular inflammation for example anterior and posterior uveitis. 
• Patient with trauma or ocular injury. 
• Patient with high myopia of more than -5.00D or whose axial length more than 
25mm. 
• Refractive error more than +3D or whose axial length less than 21mm. 
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3.3.4   Control Group Inclusion Criteria. 
• Age matched to study group. 
• Subjects who has normal ophthalmic examination and normal visual field. 
• Patient who understand the nature of study and willing to sign the informed consent 
form. 
 
3.3.5 Control Group Exclusion Criteria. 
• History suggestive of other causes of optic neuropathy and optic disc abnormality. 
• History of ocular trauma. 
• Glaucoma suspect patients. 
• Impaired media opacity including cornea scar, significant cataract and vitreous 
hemorrhage. 
• Previous cerebrovascular accident (CVA) or intracranial lesion. 
• Myopic of more than -6.00D or whose axial length more than 25mm. 
• Refractive error more than +3D or whose axial length less than 21mm. 
• Impaired media opacity including cornea scar, significant cataract and vitreous 
haemorrhage.  
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3.4 Sample Size Estimation. 
Sample size calculation determined by using PS (power and sample size) Software 2010. 
Sample size done was based on each specific objective. 
 
1) To determine PVEP parameters in NAION patients and Control: 
Confident interval (C.I) α = 0.05, study power (β) = 0.8 (80%), detectable difference 
between affected patient and unaffected patient (δ) = 8.0 (Parisi V et al 2008) Ratio 
NAION: control (1:1), M=1, n=19, total sample needed (n=10% drop out) will be 21 
samples. 
 
2) To determine PVEP parameters in NAION patients and Control: 
Confident interval (C.I) α = 0.05, study power (β) = 0.8 (80%), detectable difference 
between affected patient and unaffected patient (δ) = 8.0 (Parisi V et al 2008) Ratio 
NAION: control (1:1), M=1, n=19, total sample needed (n=10% drop out) will be 21 
samples. 
 
3) To determine RNFL analysis in NAION patients and Control: 
Confident interval (C.I) α = 0.05, study power (β) = 0.8 (80%), detectable difference 
between affected patient and unaffected patient (δ) = 53.0 (Bellusci C et al 2008) 
Ratio NAION: control (1:1), M=1, n=19, total sample needed (n=10% drop out) will 
be 21 samples. 
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For our fourth and fifth specific objectives; correlation electrophysiology test with RNFL 
analysis, to our best knowledge there were limited previous study done. The sample size 
calculation was based on above calculation. Since the largest sample obtained was 21 
samples, we had decided to recruit 21 samples on each arm for each of our specific objective. 
 
3.5 Definition of Terms.  
 
a) The Nonarteritic Anterior Ischaemic Optic Neuropathy (NAION) 
The diagnosis of NAION are based on clinical symptoms, signs and visual field defect. 
The ischemic optic neuropathy decompression trial (IONDT) clinical trials (1998) stated 
that patients with sudden onset of unilateral vision loss, with relative afferent pupillary 
defect (RAPD) positive, swollen optic disc and visual field defect are considered criteria 
to diagnose NAION. Apart from this, patients also has no symptoms or signs to suggest 
Giant Cell Arteritis (headache, pain at temporal area, tender and palpable thickened 
temporal artery with raised Erythrocyte Sedimentation Rate (ESR) and C-Reactive 
Protein (CRP)). 
 
b) Relative afferent pupillary defect (RAPD) 
It is elicited by swinging flashlight test to evaluate any optic nerve damage. This test is 
very useful for detecting NAION and can differentiate it with other disease for example 
diabetic papillitis. There is less pupillomotor stimulation reaching the brainstem when the 
light shines into the eye with NAION, thus diminished in pupillary response. 
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c) The retinal nerve fiber layer (RNFL) thickness 
The retinal nerve fiber layer (RNFL) is formed by the radial expansion of the fibers of the 
optic nerve. Character of this structure around peripapillary area can facilitate optic 
neuropathies especially in glaucoma. Ocular Coherence Tomography (OCT) is a 
promising new modality that uses back reflected infrared light (820nm) to produce high 
resolution cross-sectional images of the RNFL. In evaluating a NAION patient, OCT 
generate optic nerve head (ONH) image includes in 3-dimentionals image and 
peripapillary retina nerve fiber layer (RNFL) parameters to detect thinning area affected 
by ischaemic insult. The Fast RNFL Thickness protocol on OCT was used to yield 3.4-
mm-diameter circular scans for each eye. Presence of uniform signal intensity, strong 
reflectance signal from the RNFL (more than 6/10) and the retinal pigment epithelium 
resulting in clear demarcation of both layers without the absence of any part of image 
constituted a good-quality scan. The parameters calculated are average RNFL thickness, 
mapped in the four quadrants; superior, inferior, nasal, and temporal field area. Coloured 
coded green for normal, yellow for suspicious and red for damage RNFL. (Prashant 
Naithani et al., 2007).  
